Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009;3(1):e371.
doi: 10.1371/journal.pntd.0000371. Epub 2009 Jan 27.

Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures

Affiliations

Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures

Andres G Lescano et al. PLoS Negl Trop Dis. 2009.

Abstract

Background: Neurocysticercosis accounts for 30%-50% of all late-onset epilepsy in endemic countries. We assessed the clustering patterns of Taenia solium human cysticercosis seropositivity and seizures around tapeworm carriers in seven rural communities in Peru.

Methodology: The presence of T. solium-specific antibodies was defined as one or more positive bands in the enzyme-linked immunoelectrotransfer blot (EITB). Neurocysticercosis-related seizures cases were diagnosed clinically and had positive neuroimaging or EITB.

Principal findings: Eleven tapeworm carriers were identified by stool microscopy. The seroprevalence of human cysticercosis was 24% (196/803). Seroprevalence was 21% >50 m from a carrier and increased to 32% at 1-50 m (p = 0.047), and from that distance seroprevalence had another significant increase to 64% at the homes of carriers (p = 0.004). Seizure prevalence was 3.0% (25/837) but there were no differences between any pair of distance ranges (p = 0.629, Wald test 2 degrees of freedom).

Conclusion/significance: We observed a significant human cysticercosis seroprevalence gradient surrounding current tapeworm carriers, although cysticercosis-related seizures did not cluster around carriers. Due to differences in the timing of the two outcomes, seroprevalence may reflect recent T. solium exposure more accurately than seizure frequency.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Proportion seroprevalence of human cysticercosis and location of T. solium tapeworm carriers and NCC-related cases, Tumbes, Peru, 1999.
Two households with tapeworm carriers in Matapalo are virtually superimposed and cannot be differentiated visually. In the absence of defined community boundaries, straight lines were drawn to delimit villages respecting the self-reported area of residence data provided by each household.
Figure 2
Figure 2. Household-level prevalence of human cysticercosis seroprevalence and NCC-related seizure by distance to the nearest T. solium tapeworm carrier, Tumbes, Peru, 1999.
Observed prevalence rates in both figures are slightly jittered, and seizure frequencies 50% and 100% are represented as 40%.

Similar articles

Cited by

References

    1. Garcia HH, Gonzalez AE, Evans CA, Gilman RH Cysticercosis Working Group in Peru. Taenia solium cysticercosis. Lancet. 2003;362:547–556. - PMC - PubMed
    1. Garcia HH, Del Brutto OH Cysticercosis Working Group in Peru. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol. 2005;4:653–661. - PubMed
    1. Rajkotia Y, Lescano AG, Gilman RH, Cornejo C, Garcia HH, et al. Economic burden of cysticercosis: results from Peru. Trans R Soc Trop Med Hyg. 2007;101:840–846. - PubMed
    1. Garcia HH, Del Brutto OH. Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Peru. Neurology. 1999;53:1582–1584. - PubMed
    1. Gilman RH, Del Brutto OH, Garcia HH, Martinez M. Prevalence of taeniosis among patients with neurocysticercosis is related to severity of infection. The Cysticercosis Working Group in Peru. Neurology. 2000;55:1062. - PubMed

Publication types

MeSH terms

Substances